Vascular Access Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Vascular Access Devices Market is segmented by Device Type (Central Vascular Access Devices and Peripheral Vascular Access Devices), Application, End-User, and Geography

Market Snapshot

Vascular Access Devices
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global vascular access devices market is expected to register a CAGR of nearly 6.5% during the forecast period. Over the past decade, there has been a rise in the prevalence of several chronic diseases that need vascular access treatment. Some of the major chronic diseases include cancer, kidney failure, and heart diseases, among others. Along with these, there are several lifestyle disorders relating to chronic and non-communicable disease conditions, such as hypertension, diabetes, obesity, and depression, among others, which need critical care during their hospitalization.

The prevalence of end-stage renal disease (ESRD), worldwide, is further increasing at a significant rate, resulting in chronic kidney disease (CKD). In 2017, in the United States, around 30 million people (15% of US adults) were found suffering from chronic kidney disease (CKD). CKD was found to be more common in women (16%) than in men (13%). For patients undergoing dialysis treatment, the ideal method of vascular access is through an arteriovenous fistula (ANF), by referring to a nephrologist about replacement therapy. The vascular access catheter devices are also significantly used in the case of chemotherapies.

According to the Center for Disease Control and Prevention (CDC), in the United States, nearly 0.65 million cancer patients receive chemotherapy in an outpatient oncology clinic annually. With the rising prevalence of chronic diseases and lifestyle disorders, the vascular access procedures are increasingly being used for intravenous antibiotic treatment, long intravenous nutritional support, and drawing of blood samples. Hence this is expected to draw the attention of several multinational medical devices companies to invest and launch new products, thus, acting as one of the major drivers for this market.

Scope of the Report

As per the scope of the report, vascular access devices (VADs) are inserted into the veins for diagnostic and therapeutic reasons, such as blood sampling, central venous pressure readings, administration of medication, fluids, total parenteral nutrition (TPN), and blood transfusions. These are inserted peripherally or centrally. The choice of device for each patient differs and multiple types of devices may be required at a time, as a single device may not be able to meet all the requirements.

By Device Type
Central Vascular Access Devices
Peripherally Inserted Central Catheters
Percutaneous Non-tunneled Catheters
Other Central Vascular Access Devices
Peripheral Vascular Access Devices
Peripheral Catheter
Midline Catheter
Other Peripheral Vascular Access Devices
By Application
Administration of Drugs
Administration of Fluid and Nutrition
Diagnotics and Testing
Other Applications
By End User
Diagnostic Centers
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Administration of Drugs is Expected to Show a Large Share in the Application Segment

The drug administration segment is estimated to account for the largest share of the market as the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases. Catheters are used for a variety of functions, including administering drugs, drawing blood, and specialized treatments like hemodialysis. Vascular access catheters can be inserted either peripherally in a patient’s arm or centrally, such as in the patient’s jugular. 

Heart diseases.png

North America to Dominate the Vascular Access Devices Market Over the Forecast Period

North America segment is expected to account for the largest share of the market that can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.

Additionally, in a large number of cases of all the end-stage renal disease (ESRD), dialysis patients are treated via a catheter, which is performed in an outpatient setting, thus, reducing the hospitalization of ESRD patients by allowing the non-emergency interventional procedures to be carried out. The factors, such as government guidelines for the regulation of medical devices by the company, and better healthcare infrastructure, etc., play a key role in increasing the business and in the launching of new products by multinational companies, and thereby, contributing the market growth.


Competitive Landscape

The vascular access devices market is highly competitive and there are several small to mid-sized companies that are posing strong competition to gain the market share. However, few companies that are doing a good business in the market include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation, and Fresenius Medical Care.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Lifestyle-related Disorders

      2. 4.2.2 Increasing Number of Chemotherapy Procedures with High Hospitalization Rates

      3. 4.2.3 Rising Use of Vascular Access Devices among Paediatric Patients

    3. 4.3 Market Restraints

      1. 4.3.1 Risks Associated with Catheter Usage

      2. 4.3.2 Stringent Regulations and Product Recalls

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Device Type

      1. 5.1.1 Central Vascular Access Devices

        1. Peripherally Inserted Central Catheters

        2. Percutaneous Non-tunneled Catheters

        3. Other Central Vascular Access Devices

      2. 5.1.2 Peripheral Vascular Access Devices

        1. Peripheral Catheter

        2. Midline Catheter

        3. Other Peripheral Vascular Access Devices

    2. 5.2 By Application

      1. 5.2.1 Administration of Drugs

      2. 5.2.2 Administration of Fluid and Nutrition

      3. 5.2.3 Diagnotics and Testing

      4. 5.2.4 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospital/Clinic

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Melsungen AG

      2. 6.1.2 Baxter International Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Fresenius Medical Care AG & Co. KGaA

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Nipro Medical Corporation

      7. 6.1.7 Siemens Healthineers

      8. 6.1.8 Smiths Medical Inc.

      9. 6.1.9 Teleflex Incorporated

      10. 6.1.10 Terumo Corporation

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Vascular Access Devices Market market is studied from 2018 - 2026.

The Vascular Access Devices Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation, Fresenius Medical Care are the major companies operating in Vascular Access Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!